Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer's Disease-Studies on Relation to Effective Target Occupancy.

Hoffmann T, Meyer A, Heiser U, Kurat S, Böhme L, Kleinschmidt M, Bühring KU, Hutter-Paier B, Farcher M, Demuth HU, Lues I, Schilling S.

J Pharmacol Exp Ther. 2017 Jul;362(1):119-130. doi: 10.1124/jpet.117.240614. Epub 2017 Apr 26.

PMID:
28446518
2.

Chlorothiophenecarboxamides as P1 surrogates of inhibitors of blood coagulation factor Xa.

Mederski WW, Cezanne B, van Amsterdam C, Bühring KU, Dorsch D, Gleitz J, März J, Tsaklakidis C.

Bioorg Med Chem Lett. 2004 Dec 6;14(23):5817-22.

PMID:
15501047
3.

Different effects of exercise on plasma concentrations of nebivolol, bisoprolol and carvedilol.

Stoschitzky K, Stoschitzky G, Klein W, Müller F, Bühring K, Lamprecht G, Lindner W.

Cardiovasc Drugs Ther. 2004 Mar;18(2):135-8.

PMID:
15162075
4.
5.

Pharmacokinetics and first clinical experiences with an antihypertensive dopamine (DA2) agonist.

Meyer W, Bühring KU, Steiner K, Ungethüm W, Schnurr E.

Eur Heart J. 1992 Sep;13 Suppl D:121-8.

PMID:
1356782
6.

Bisoprolol--comparative toxicokinetic study after oral and conjunctival administration in beagles.

Bühring KU, Metallinos A, Jakobs N, von Landenberg F, Merck E.

Lens Eye Toxic Res. 1990;7(3-4):335-45.

PMID:
1983105
7.

The melanin binding of bisoprolol and its toxicological relevance.

Steiner K, Bühring KU, Merck E.

Lens Eye Toxic Res. 1990;7(3-4):319-33.

PMID:
1983104
8.

Basic pharmacokinetics of bisoprolol, a new highly beta 1-selective adrenoceptor antagonist.

Leopold G, Pabst J, Ungethüm W, Bühring KU.

J Clin Pharmacol. 1986 Nov-Dec;26(8):616-21.

PMID:
2878941
10.

Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.

Leopold G, Ungethüm W, Pabst J, Simane Z, Bühring KU, Wiemann H.

Br J Clin Pharmacol. 1986 Sep;22(3):293-300.

11.

Concentration kinetics of propranolol, bisoprolol, and atenolol in humans assessed with chemical detection and a subtype-selective beta-adrenoceptor assay.

Wellstein A, Palm D, Belz GG, Leopold G, Bühring KU, Pabst J.

J Cardiovasc Pharmacol. 1986;8 Suppl 11:S41-5.

PMID:
2439797
12.

Pharmacokinetics and metabolism of bisoprolol-14C in three animal species and in humans.

Bühring KU, Sailer H, Faro HP, Leopold G, Pabst J, Garbe A.

J Cardiovasc Pharmacol. 1986;8 Suppl 11:S21-8.

PMID:
2439794
13.

[Esmaloride--a new potassium neutral diuretic combination. Clinical pharmacologic properties].

Pabst J, Leopold G, Ungethüm W, Simane Z, Bühring KU.

Fortschr Med. 1985 Feb 14;103(6):125-9. German. No abstract available.

PMID:
3988214
14.

Sucralfate: pharmacokinetics, metabolism and selective binding to experimental gastric and duodenal ulcers in animals.

Steiner K, Bühring KU, Faro HP, Garbe A, Nowak H.

Arzneimittelforschung. 1982;32(5):512-8.

PMID:
6896647
15.
16.

[Metabolism of pramiverine (author's transl)].

Diekmann HW, Bühring KU, Garbe A, Nowak H.

Arzneimittelforschung. 1976 Apr;26(4b):722-6. German.

PMID:
821495

Supplemental Content

Loading ...
Support Center